JAMES PATTERSON MD
Prescription History 1972600708
Internal Medicine - Hematology & Oncology in West Chester, PA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for JAMES PATTERSON MD, an active Hematology & Oncology specialist practicing in West Chester, PA. Our medical registry currently tracks 15 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 362 documented patient claims. Among these therapy options, the most frequently utilized medication is Ondansetron Hcl, which accounts for 51 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other PA PrescribersVs. PA Avg |
|---|---|---|---|
| Ondansetron Hcl | 51 | $17.83 | ▲ More than typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. In 2023, this provider wrote 51 Medicare prescriptions for Ondansetron Hcl, about 2 times the volume of the typical Pennsylvania prescriber of this medication (26). Medicare paid an average of $17.83 per fill, versus $15.25 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 57 30-Day Fills standardized to 30-day supplies 1,067 Days of Medication total across all patients in 2023 | |||
| EliquisApixaban | 49 | $1,067.48 | ▼ Less than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. In 2023, this provider wrote 49 Medicare prescriptions for Eliquis, about half the volume of the typical Pennsylvania prescriber of this medication (92). Medicare paid an average of $1,067.48 per fill, versus $730.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 91 30-Day Fills standardized to 30-day supplies 2,730 Days of Medication total across all patients in 2023 | |||
| XareltoRivaroxaban | 45 | $1,178.14 | ≈ Typical |
About Xarelto: Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. Show more ▾ It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood. A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. In 2023, this provider wrote 45 Medicare prescriptions for Xarelto, about the same volume as the typical Pennsylvania prescriber of this medication (48). Medicare paid an average of $1,178.14 per fill, versus $800.52 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 99 30-Day Fills standardized to 30-day supplies 2,970 Days of Medication total across all patients in 2023 | |||
| ImbruvicaIbrutinib | 30 | $16,339.71 | ≈ Typical |
About Imbruvica: This medication is used to treat certain cancers (such as mantle cell or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system). In 2023, this provider wrote 30 Medicare prescriptions for Imbruvica, about the same volume as the typical Pennsylvania prescriber of this medication (31). Medicare paid an average of $16,339.71 per fill, versus $14,546.74 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30 30-Day Fills standardized to 30-day supplies 860 Days of Medication total across all patients in 2023 | |||
| Acyclovir | 27 | $35.15 | ≈ Typical |
About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾ It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. In 2023, this provider wrote 27 Medicare prescriptions for Acyclovir, about the same volume as the typical Pennsylvania prescriber of this medication (27). Medicare paid an average of $35.15 per fill, versus $26.32 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 47 30-Day Fills standardized to 30-day supplies 1,410 Days of Medication total across all patients in 2023 | |||
| Allopurinol | 23 | $6.28▼ below PA avg | ▼ Less than typical |
About Allopurinol: Allopurinol is used to treat gout and certain types of kidney stones. Show more ▾ It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems. A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. In 2023, this provider wrote 23 Medicare prescriptions for Allopurinol, about half the volume of the typical Pennsylvania prescriber of this medication (50). Medicare paid an average of $6.28 per fill, versus $14.17 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 31 30-Day Fills standardized to 30-day supplies 930 Days of Medication total across all patients in 2023 | |||
| Prednisone | 22 | $8.93 | ▼ Less than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 22 Medicare prescriptions for Prednisone, about half the volume of the typical Pennsylvania prescriber of this medication (48). Medicare paid an average of $8.93 per fill, versus $5.96 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36 30-Day Fills standardized to 30-day supplies 910 Days of Medication total across all patients in 2023 | |||
| Prochlorperazine Maleate | 19 | $6.85▼ below PA avg | ▼ Less than typical |
About Prochlorperazine Maleate: This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Show more ▾ Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612) In 2023, this provider wrote 19 Medicare prescriptions for Prochlorperazine Maleate, about 66% of the volume of the typical Pennsylvania prescriber of this medication (29). Medicare paid an average of $6.85 per fill, versus $18.72 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 19 30-Day Fills standardized to 30-day supplies 138 Days of Medication total across all patients in 2023 | |||
| Abiraterone Acetate | 18 | $5,689.13 | ▼ Less than typical |
About Abiraterone Acetate: This medication is used to treat prostate cancer. Show more ▾ Abiraterone belongs to a class of drugs known as anti-androgens (anti-testosterone). Testosterone, a natural hormone, helps prostate cancer to grow and spread. Abiraterone works by blocking the production of testosterone, thereby slowing the growth and spread of prostate cancer. This medication should not be given to women or children. An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER. In 2023, this provider wrote 18 Medicare prescriptions for Abiraterone Acetate, about half the volume of the typical Pennsylvania prescriber of this medication (40). Medicare paid an average of $5,689.13 per fill, versus $3,499.10 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18 30-Day Fills standardized to 30-day supplies 540 Days of Medication total across all patients in 2023 | |||
| Oxycodone Hcl | 18 | $15.81▼ below PA avg | ▼ Less than typical |
About Oxycodone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾ Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A semisynthetic derivative of CODEINE. In 2023, this provider wrote 18 Medicare prescriptions for Oxycodone Hcl, about a third of the volume of the typical Pennsylvania prescriber of this medication (54). Medicare paid an average of $15.81 per fill, versus $22.66 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 18 30-Day Fills standardized to 30-day supplies 239 Days of Medication total across all patients in 2023 | |||
| Hydroxyurea | 15 | $33.15▼ below PA avg | ▼ Less than typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2023, this provider wrote 15 Medicare prescriptions for Hydroxyurea, about half the volume of the typical Pennsylvania prescriber of this medication (33). Medicare paid an average of $33.15 per fill, versus $33.87 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 36.6 30-Day Fills standardized to 30-day supplies 1,098 Days of Medication total across all patients in 2023 | |||
| RevlimidLenalidomide | 12 | $18,148.67▼ below PA avg | ▼ Less than typical |
About Revlimid: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2023, this provider wrote 12 Medicare prescriptions for Revlimid, about a third of the volume of the typical Pennsylvania prescriber of this medication (35). Medicare paid an average of $18,148.67 per fill, versus $18,521.15 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 12 30-Day Fills standardized to 30-day supplies 336 Days of Medication total across all patients in 2023 | |||
| Gabapentin | 11 | $1.81▼ below PA avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2023, this provider wrote 11 Medicare prescriptions for Gabapentin, about 11% of the volume of the typical Pennsylvania prescriber of this medication (97). Medicare paid an average of $1.81 per fill, versus $21.72 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
| Imatinib Mesylate | 11 | $493.28▼ below PA avg | ▼ Less than typical |
About Imatinib Mesylate: This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). Show more ▾ It works by slowing or stopping the growth of cancer cells. Imatinib may also be used to treat certain immune system disorders (such as aggressive systemic mastocytosis, hypereosinophilic syndrome). A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. In 2023, this provider wrote 11 Medicare prescriptions for Imatinib Mesylate, about half the volume of the typical Pennsylvania prescriber of this medication (22). Medicare paid an average of $493.28 per fill, versus $2,955.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
| LoperamideLoperamide Hcl | 11 | $21.29▼ below PA avg | ▼ Less than typical |
About Loperamide: See also Warning section. Show more ▾ This medication is used to treat sudden diarrhea (including traveler's diarrhea). It works by slowing down the movement of the gut. This decreases the number of bowel movements and makes the stool less watery. Loperamide is also used to reduce the amount of discharge in patients who have undergone an ileostomy. It is also used to treat on-going diarrhea in people with inflammatory bowel disease. Loperamide treats only the symptoms, not the cause of the diarrhea (such as infection). Treatment of other symptoms and the cause of the diarrhea should be determined by your doctor. One of the long-acting synthetic ANTIDIARRHEALS; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally. In 2023, this provider wrote 11 Medicare prescriptions for Loperamide, about half the volume of the typical Pennsylvania prescriber of this medication (22). Medicare paid an average of $21.29 per fill, versus $28.42 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 13 30-Day Fills standardized to 30-day supplies 180 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for JAMES PATTERSON MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this West Chester, PA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among PA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
